GRWD1 and neoplasm: For instance, Robles et al. found that methylation of the HOXA9 promoter was associated with a high risk in patients with stage I LUAD [33], whereas Sugimoto et al. found that the aberrant methylation of GRWD1 may be a protective factor in tumor development.